Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02823990
Title TG4010 and Nivolumab in Patients With Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, Davis
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of California San Diego San Diego California 92103 United States Details
UCSF Medical Center-Mount Zion San Francisco California 94115 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field